Patrizia Nanni
Patrizia Nanni
Verified email at
Cited by
Cited by
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice
S Rovero, A Amici, E Di Carlo, R Bei, P Nanni, E Quaglino, P Porcedda, ...
The Journal of Immunology 165 (9), 5133-5142, 2000
Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
K Boggio, G Nicoletti, E Di Carlo, F Cavallo, L Landuzzi, C Melani, ...
The Journal of experimental medicine 188 (3), 589-596, 1998
Vaccines for tumour prevention
PL Lollini, F Cavallo, P Nanni, G Forni
Nature Reviews Cancer 6 (3), 204-216, 2006
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice
P Nanni, G Nicoletti, C De Giovanni, L Landuzzi, E Di Carlo, F Cavallo, ...
The Journal of experimental medicine 194 (9), 1195-1206, 2001
2011: the immune hallmarks of cancer
F Cavallo, C De Giovanni, P Nanni, G Forni, PL Lollini
Cancer Immunology, Immunotherapy 60 (3), 319-326, 2011
Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice
K Scotlandi, S Benini, P Nanni, PL Lollini, G Nicoletti, L Landuzzi, M Serra, ...
Cancer research 58 (18), 4127-4131, 1998
TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma
P Nanni, C De Giovanni, PL Lollini, G Nicoletti, G Prodi
Clinical & experimental metastasis 1 (4), 373-380, 1983
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor …
A Allione, M Consalvo, P Nanni, PL Lollini, F Cavallo, M Giovarelli, ...
Cancer research 54 (23), 6022-6026, 1994
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing’s sarcoma cells
S Benini, MC Manara, N Baldini, V Cerisano, M Serra, M Mercuri, ...
Clinical Cancer Research 7 (6), 1790-1797, 2001
Preclinical in vivo study of new insulin-like growth factor-I receptor–specific inhibitor in Ewing's sarcoma
MC Manara, L Landuzzi, P Nanni, G Nicoletti, D Zambelli, PL Lollini, ...
Clinical Cancer Research 13 (4), 1322-1330, 2007
Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.
R Ferracini, M Olivero, MFR Di, M Martano, CG De, P Nanni, G Basso, ...
Oncogene 12 (8), 1697-1705, 1996
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells
K Scotlandi, C Maini, MC Manara, S Benini, M Serra, V Cerisano, ...
Cancer gene therapy 9 (3), 296-307, 2002
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin.
EC Di, MG Diodoro, K Boggio, A Modesti, M Modesti, P Nanni, G Forni, ...
Laboratory investigation; a journal of technical methods and pathology 79 …, 1999
CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine
A Comes, O Rosso, AM Orengo, E Di Carlo, C Sorrentino, R Meazza, ...
The Journal of Immunology 176 (3), 1750-1758, 2006
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-γ and B cell dependent
P Nanni, L Landuzzi, G Nicoletti, C De Giovanni, I Rossi, S Croci, A Astolfi, ...
The Journal of Immunology 173 (4), 2288-2296, 2004
A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate.
F Pannuti, A Martoni, GR Lenaz, E Piana, P Nanni
Cancer treatment reports 62 (4), 499-504, 1978
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice
K Boggio, E Di Carlo, S Rovero, F Cavallo, E Quaglino, PL Lollini, ...
Cancer Research 60 (2), 359-364, 2000
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine
C De Giovanni, G Nicoletti, L Landuzzi, A Astolfi, S Croci, A Comes, ...
Cancer research 64 (11), 4001-4009, 2004
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells
S Croci, L Landuzzi, A Astolfi, G Nicoletti, A Rosolen, F Sartori, MY Follo, ...
Cancer research 64 (5), 1730-1736, 2004
Inhibition of tumor growth and enhancement of metastasis after transfection of the γ‐interferon gene
PL Lollini, MC Bosco, F Cavallo, C De Giovanni, M Giovarelli, L Landuzzi, ...
International journal of cancer 55 (2), 320-329, 1993
The system can't perform the operation now. Try again later.
Articles 1–20